Fischer Medical Ventures Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Limited has informed the stock exchanges that its trading window will remain closed from October 1, 2025, until 48 hours after the declaration of its Unaudited Financial Results for the quarter ended September 30, 2025. During this period, promoters, directors, and designated persons are prohibited from trading in the company's equity shares. This is a standard insider trading compliance measure under SEBI regulations. A separate intimation regarding the board meeting to approve the Q2 results will be sent later.
This is a routine compliance filing and does not directly affect shareholders. However, it signals that the company's Q2 FY26 financial results announcement is approaching, which investors should watch for as it may influence the stock price.